Hong Kong stocks climb, led by pharmaceutical, tech stocks

WuXi Biologics (Cayman)

06/10/2026 06:04

HONG KONG, Oct 6 (Reuters) - Hong Kong stocks climbed on Tuesday, tracking a firmer overseas market with pharmaceutical and technology stocks leading the gains, overpowering selling pressure on property developers.
** Hong Kong benchmark Hang Seng .HSI was up 0.78% by midday, and the Hang Seng China Enterprises Index .HSCE climbed 0.82%. 
** The Hang Seng Biotech Index .HSBIO rose nearly 3% and the Hang Seng Tech .HSTECH gained 0.87%.
** WuXi Biologics 2269.HK and Sino Biopharmaceutical 1177.HK rose 4.2% and 4.1%, respectively, leading gains in the benchmark Hang Seng Index.  
** Sunny Optical 2382.HK, Baidu 9888.HK, Kuaishou 1024.HK and Alibaba 9988.HK rose between 2.8% and 3.7%.
** China's onshore financial markets were closed for China's National Day and will reopen on October 8.
** Key property developers slipped, with Sun Hung Kai Properties 0016.HK down 0.4% and CK Asset 1113.HK down 0.3%. 
** "We expect (residential) prices to consolidate throughout 2026," brokerage UOB Kay Hian said.  
** New World Development 0017.HK fell 3.8% after the developer launched a debt exchange offer that would allow bondholders to swap some notes due in 2027 and 2028 for new secured debt maturing in 2032. 


 (Reporting by Donny Kwok; Editing by Sonia Cheema)
 ((donny.kwok@thomsonreuters.com; +852 3462 7745;))